| Allergic rhinitis and its impact on asthma (ARIA) 2008 J Bousquet, N Khaltaev, AA Cruz, J Denburg, WJ Fokkens, A Togias, ... Allergy 63, 8-160, 2008 | 11462* | 2008 |
| International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma KF Chung, SE Wenzel, JL Brozek, A Bush, M Castro, PJ Sterk, IM Adcock, ... European respiratory journal 43 (2), 343-373, 2014 | 4587 | 2014 |
| Global strategy for asthma management and prevention: GINA executive summary ED Bateman, SS Hurd, PJ Barnes, J Bousquet, JM Drazen, M FitzGerald, ... European Respiratory Journal 31 (1), 143-178, 2007 | 4452 | 2007 |
| Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study ED Bateman, HA Boushey, J Bousquet, WW Busse, TJH Clark, ... American journal of respiratory and critical care medicine 170 (8), 836-844, 2004 | 2739 | 2004 |
| An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical … HK Reddel, DR Taylor, ED Bateman, LP Boulet, HA Boushey, WW Busse, ... American journal of respiratory and critical care medicine 180 (1), 59-99, 2009 | 2247 | 2009 |
| Global asthma prevalence in adults: findings from the cross-sectional world health survey T To, S Stanojevic, G Moores, AS Gershon, ED Bateman, AA Cruz, ... BMC public health 12, 1-8, 2012 | 1900 | 2012 |
| Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase … M Castro, J Zangrilli, ME Wechsler, ED Bateman, GG Brusselle, P Bardin, ... The Lancet Respiratory Medicine 3 (5), 355-366, 2015 | 1323 | 2015 |
| Identifying ‘well-controlled’and ‘not well-controlled’asthma using the Asthma Control Questionnaire EF Juniper, J Bousquet, L Abetz, ED Bateman, Goal Committee Respiratory medicine 100 (4), 616-621, 2006 | 1160 | 2006 |
| Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes HK Reddel, LB Bacharier, ED Bateman, CE Brightling, GG Brusselle, ... American journal of respiratory and critical care medicine 205 (1), 17-35, 2022 | 1069 | 2022 |
| A summary of the new GINA strategy: a roadmap to asthma control HK Reddel, ED Bateman, A Becker, LP Boulet, AA Cruz, JM Drazen, ... European Respiratory Journal 46 (3), 622-639, 2015 | 1035 | 2015 |
| Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma PM O'Byrne, H Bisgaard, PP Godard, M Pistolesi, M Palmqvist, Y Zhu, ... American journal of respiratory and critical care medicine 171 (2), 129-136, 2005 | 972 | 2005 |
| COPD in never smokers: results from the population-based burden of obstructive lung disease study B Lamprecht, MA McBurnie, WM Vollmer, G Gudmundsson, T Welte, ... Chest 139 (4), 752-763, 2011 | 892 | 2011 |
| Tiotropium in asthma poorly controlled with standard combination therapy HAM Kerstjens, M Engel, R Dahl, P Paggiaro, E Beck, M Vandewalker, ... New England Journal of Medicine 367 (13), 1198-1207, 2012 | 858 | 2012 |
| Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs J Bousquet, HJ Schünemann, B Samolinski, P Demoly, ... Journal of Allergy and Clinical Immunology 130 (5), 1049-1062, 2012 | 833 | 2012 |
| Inhaled combined budesonide–formoterol as needed in mild asthma PM O’Byrne, JM FitzGerald, ED Bateman, PJ Barnes, N Zhong, C Keen, ... New England Journal of Medicine 378 (20), 1865-1876, 2018 | 758 | 2018 |
| A new perspective on concepts of asthma severity and control DR Taylor, ED Bateman, LP Boulet, HA Boushey, WW Busse, TB Casale, ... European Respiratory Journal 32 (3), 545-554, 2008 | 742 | 2008 |
| A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol JF Donohue, JA van Noord, ED Bateman, SJ Langley, A Lee, TJ Witek Jr, ... Chest 122 (1), 47-55, 2002 | 736 | 2002 |
| Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial KF Rabe, ED Bateman, D O'Donnell, S Witte, D Bredenbröker, TD Bethke The Lancet 366 (9485), 563-571, 2005 | 634 | 2005 |
| As-needed budesonide–formoterol versus maintenance budesonide in mild asthma ED Bateman, HK Reddel, PM O’Byrne, PJ Barnes, N Zhong, C Keen, ... New England Journal of Medicine 378 (20), 1877-1887, 2018 | 611 | 2018 |
| Ultramarathon running and upper respiratory tract infections-an epidemiological survey ED Peters, EM & Bateman South African Medical Journal 64 (16), 582-584, 1983 | 574 | 1983 |
